Application of PD-1 Monoclonal Antibody in Combination With IL-2 and CapeOX in Organ Preservation Therapy for Ultra-Low Localized Advanced Rectal Cancer: A Single-center, Single-arm, Open-label Clinical Study (PICTURE)
Latest Information Update: 23 Jul 2024
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary) ; Tislelizumab (Primary) ; Interleukin-2
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- Acronyms PICTURE
Most Recent Events
- 23 Jul 2024 New trial record